Annual Operating Expenses
$40.50 M
-$30.42 M-42.89%
31 December 2023
Summary:
Seelos Therapeutics annual total operating expenses is currently $40.50 million, with the most recent change of -$30.42 million (-42.89%) on 31 December 2023. During the last 3 years, it has risen by +$21.74 million (+115.89%). SEEL annual operating expenses is now -42.89% below its all-time high of $70.92 million, reached on 31 December 2022.SEEL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.14 M
-$2.92 M-48.16%
30 June 2024
Summary:
Seelos Therapeutics quarterly total operating expenses is currently $3.14 million, with the most recent change of -$2.92 million (-48.16%) on 30 June 2024. Over the past year, it has dropped by -$9.46 million (-75.09%). SEEL quarterly operating expenses is now -88.53% below its all-time high of $27.37 million, reached on 31 December 2021.SEEL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.9% | -75.1% |
| 3 y3 years | +115.9% | -71.2% |
| 5 y5 years | +342.7% | -14.7% |
SEEL Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.9% | +115.9% | -88.5% | at low |
| 5 y | 5 years | -42.9% | +342.7% | -88.5% | at low |
| alltime | all time | -42.9% | +937.5% | -88.5% | +201.7% |
Seelos Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $3.14 M(-48.2%) |
| Mar 2024 | - | $6.05 M(-24.4%) |
| Dec 2023 | $40.50 M(-42.9%) | $8.01 M(-36.4%) |
| Sept 2023 | - | $12.60 M(+15.1%) |
| June 2023 | - | $10.95 M(+22.6%) |
| Mar 2023 | - | $8.93 M(-51.1%) |
| Dec 2022 | $70.92 M(+15.0%) | $18.26 M(+4.9%) |
| Sept 2022 | - | $17.41 M(-18.0%) |
| June 2022 | - | $21.24 M(+51.6%) |
| Mar 2022 | - | $14.01 M(-48.8%) |
| Dec 2021 | $61.67 M(+228.7%) | $27.37 M(+150.9%) |
| Sept 2021 | - | $10.91 M(+61.1%) |
| June 2021 | - | $6.77 M(-59.2%) |
| Mar 2021 | - | $16.61 M(+184.2%) |
| Dec 2020 | $18.76 M(-36.9%) | $5.84 M(+43.1%) |
| Sept 2020 | - | $4.08 M(+23.0%) |
| June 2020 | - | $3.32 M(-39.7%) |
| Mar 2020 | - | $5.51 M(-46.7%) |
| Dec 2019 | $29.75 M(+225.2%) | $10.33 M(+180.6%) |
| Sept 2019 | - | $3.68 M(+8.5%) |
| June 2019 | - | $3.39 M(-72.5%) |
| Mar 2019 | - | $12.34 M(+76.2%) |
| Dec 2018 | $9.15 M(-14.3%) | $7.00 M(+544.3%) |
| Sept 2018 | - | $1.09 M(-51.4%) |
| June 2018 | - | $2.24 M(-4.9%) |
| Mar 2018 | - | $2.35 M(-11.2%) |
| Dec 2017 | $10.67 M(-21.9%) | $2.65 M(-28.7%) |
| Sept 2017 | - | $3.72 M(+52.2%) |
| June 2017 | - | $2.44 M(+31.7%) |
| Mar 2017 | - | $1.85 M(-26.1%) |
| Dec 2016 | $13.66 M(-45.7%) | $2.51 M(+45.7%) |
| Sept 2016 | - | $1.72 M(-62.8%) |
| June 2016 | - | $4.63 M(-4.2%) |
| Mar 2016 | - | $4.83 M(-19.6%) |
| Dec 2015 | $25.16 M(-23.1%) | $6.00 M(-14.5%) |
| Sept 2015 | - | $7.02 M(+21.6%) |
| June 2015 | - | $5.78 M(-9.2%) |
| Mar 2015 | - | $6.36 M(-65.8%) |
| Dec 2014 | $32.71 M(+75.1%) | $18.63 M(+305.4%) |
| Sept 2014 | - | $4.59 M(-7.7%) |
| June 2014 | - | $4.98 M(+10.6%) |
| Mar 2014 | - | $4.50 M(+3.2%) |
| Dec 2013 | $18.68 M(-9.8%) | $4.36 M(+15.3%) |
| Sept 2013 | - | $3.79 M(-28.4%) |
| June 2013 | - | $5.29 M(+1.0%) |
| Mar 2013 | - | $5.24 M(-15.4%) |
| Dec 2012 | $20.71 M(+23.4%) | $6.19 M(+7.6%) |
| Sept 2012 | - | $5.75 M(+32.3%) |
| June 2012 | - | $4.35 M(-1.5%) |
| Mar 2012 | - | $4.42 M(+200.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $16.79 M(+36.9%) | $1.47 M(-49.2%) |
| Sept 2011 | - | $2.89 M(-65.6%) |
| June 2011 | - | $8.42 M(+110.1%) |
| Mar 2011 | - | $4.01 M(+3.4%) |
| Dec 2010 | $12.26 M(+101.7%) | $3.88 M(+48.8%) |
| Sept 2010 | - | $2.60 M(-16.5%) |
| June 2010 | - | $3.12 M(+17.0%) |
| Mar 2010 | - | $2.67 M(+36.6%) |
| Dec 2009 | $6.08 M(-45.4%) | $1.95 M(+90.5%) |
| Sept 2009 | - | $1.02 M(-27.4%) |
| June 2009 | - | $1.41 M(-16.7%) |
| Mar 2009 | - | $1.69 M(-46.5%) |
| Dec 2008 | $11.13 M(+4.4%) | $3.17 M(-1.1%) |
| Sept 2008 | - | $3.20 M(+39.9%) |
| June 2008 | - | $2.29 M(-7.4%) |
| Mar 2008 | - | $2.47 M(-34.7%) |
| Dec 2007 | $10.66 M(-3.1%) | $3.78 M(+64.2%) |
| Sept 2007 | - | $2.30 M(+2.0%) |
| June 2007 | - | $2.26 M(-2.3%) |
| Mar 2007 | - | $2.31 M(-25.0%) |
| Dec 2006 | $11.00 M(-39.3%) | $3.08 M(+27.8%) |
| Sept 2006 | - | $2.41 M(+11.6%) |
| June 2006 | - | $2.16 M(-35.3%) |
| Mar 2006 | - | $3.34 M(-45.0%) |
| Dec 2005 | $18.10 M(+2.5%) | $6.07 M(+93.4%) |
| Sept 2005 | - | $3.14 M(-27.5%) |
| June 2005 | - | $4.33 M(-5.2%) |
| Mar 2005 | - | $4.57 M(-3.6%) |
| Dec 2004 | $17.66 M(+23.2%) | $4.74 M(+0.9%) |
| Sept 2004 | - | $4.70 M(+10.9%) |
| June 2004 | - | $4.23 M(+6.0%) |
| Mar 2004 | - | $3.99 M(-18.8%) |
| Dec 2003 | $14.34 M(-48.2%) | $4.92 M(+69.0%) |
| Sept 2003 | - | $2.91 M(-14.7%) |
| June 2003 | - | $3.41 M(-210.6%) |
| Mar 2003 | - | -$3.09 M(-137.4%) |
| Dec 2002 | $27.68 M(+60.7%) | $8.26 M(+21.1%) |
| Sept 2002 | - | $6.82 M(-1.7%) |
| June 2002 | - | $6.94 M(+22.5%) |
| Mar 2002 | - | $5.66 M(-7.0%) |
| Dec 2001 | $17.23 M(+66.3%) | $6.09 M(+65.5%) |
| Sept 2001 | - | $3.68 M(-3.5%) |
| June 2001 | - | $3.81 M(+4.5%) |
| Mar 2001 | - | $3.65 M(-4.4%) |
| Dec 2000 | $10.36 M(+147.1%) | $3.81 M(+55.5%) |
| Sept 2000 | - | $2.45 M(-7.7%) |
| June 2000 | - | $2.66 M(+85.4%) |
| Mar 2000 | - | $1.43 M |
| Dec 1999 | $4.19 M(+7.4%) | - |
| Dec 1997 | $3.90 M | - |
FAQ
- What is Seelos Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Seelos Therapeutics?
- What is Seelos Therapeutics annual operating expenses year-on-year change?
- What is Seelos Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly operating expenses year-on-year change?
What is Seelos Therapeutics annual total operating expenses?
The current annual operating expenses of SEEL is $40.50 M
What is the all time high annual operating expenses for Seelos Therapeutics?
Seelos Therapeutics all-time high annual total operating expenses is $70.92 M
What is Seelos Therapeutics annual operating expenses year-on-year change?
Over the past year, SEEL annual total operating expenses has changed by -$30.42 M (-42.89%)
What is Seelos Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SEEL is $3.14 M
What is the all time high quarterly operating expenses for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly total operating expenses is $27.37 M
What is Seelos Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SEEL quarterly total operating expenses has changed by -$9.46 M (-75.09%)